RT @lbi_gol: Hög dosering av Kineret i patienter. Ser verkligen lovande ut
Hög dosering av Kineret i patienter. Ser verkligen lovande ut
RT @ArmelleID: Interleukin-1 blockade with high-dose anakinra in patients with #COVID19 Retrospective cohort study Anakinra was associat…
RT @LancetRespirMed: Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose…
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study - The Lancet Rheumatology https://t.co/vqvEbNqbY2
RT @ArmelleID: Interleukin-1 blockade with high-dose anakinra in patients with #COVID19 Retrospective cohort study Anakinra was associat…
What are you telling me? ... Anakinra 5mg/kg twice a day IV was associated with patient improvement in #COVID19? ( plus; HCQ, Lopinavir,Ritonavir) Survival 90% vs 56% at 21 days 🧐🤔 Should we be impressed?
Thé Lancet Respirator.. Article publié dans @TheLancetRheum est la première étude de cohorte rétrospective à décrire le blocage de l'IL-1 par voie intraveineuse à forte dose #anakinra chez les patients #COVID19 , #ARDS , et #hyperinflammation https://t.co
RT @LancetRespirMed: Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose…
RT @LancetRespirMed: Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose…
RT @ArmelleID: Interleukin-1 blockade with high-dose anakinra in patients with #COVID19 Retrospective cohort study Anakinra was associat…
RT @LancetRespirMed: Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study https://t.co/ZvdXxPIcR9
RT @LancetRespirMed: Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose…
RT @ArmelleID: Interleukin-1 blockade with high-dose anakinra in patients with #COVID19 Retrospective cohort study Anakinra was associat…
E' informazione scientifica corretta pubblicare uno studio con una così piccola coorte di pazienti? @MedBunker ,@biundulella ,@RobiVil @GerardoDAmico @christianrocca @MarMalagut @dottoremaevero https://t.co/6AEEGPpujl
RT @LancetRespirMed: Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose…
RT @LancetRespirMed: Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose…
RT @LancetRespirMed: Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose…
Article published in @TheLancetRheum is the first retrospective cohort study to describe IL-1 blockade with high-dose intravenous #anakinra in patients with #COVID19, #ARDS, and #hyperinflammation https://t.co/VWMNGA6ZAp https://t.co/2A7i4FhCp4
RT @ArmelleID: Interleukin-1 blockade with high-dose anakinra in patients with #COVID19 Retrospective cohort study Anakinra was associat…
RT @ArmelleID: Interleukin-1 blockade with high-dose anakinra in patients with #COVID19 Retrospective cohort study Anakinra was associat…
RT @LilyDear: L'anakinra (antagoniste des récepteurs de l'IL-1) a été associé à une réduction de la mortalité et de meilleures chances de r…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
Interleukin-1 blockade with high-dose anakinra in patients with #COVID19 Retrospective cohort study Anakinra was associated with clinical improvement https://t.co/i0R2XrrscF https://t.co/doTH53dlHV
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
Treatment with high-dose anakinra was safe and associated with clinical improvement in 72% of patients with COVID-19 and ARDS managed with non-invasive ventilation outside of the ICU. https://t.co/VJUFxVej6t.
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @AmbrizMau: Cohorte retrospectiva de pacientes con COVID-19 y SDRA tratados con VNI fuera de UCI ➡️ dosis altas de ANAKINRA fue seguro y…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
Good to see the anti-IL1 hypothesis-generating signal with retrospective cohort data. Lopinavir+ritonivir+HQ among other confounders but nice to see authors conclusion = Need RCT! #COVID19 thanks @RheumNow
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
Eller som da man ga en veldig høy dose anakinra til pasienter som var alvorlig sjuke med covid-19, og fant ut at 90 % overlevde på denne måten vs 56 % uten! 11/ https://t.co/tzeCBu46eT
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
Meanwhile in @TheLancet, #FeteDuSlip goes on. @yonatman tu ne veux pas devenir EIC du Lancet ? Horton a l'air momifié
Des résultats non randomisés en faveur de l' #anakinra dans le #Covid-19 avec détresse respiratoire #Kineret* anti-IL-1 étude italienne, de petite taille et non randomisée The Lancet Rheumatology https://t.co/fPNhKZRINR pdf libre https://t.co/OQ8jJi8gTR
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
Étude rétrospective avec tous les risques de biais que cela engendre. Un anti-inflammatoire (Anakinra) chez les patients très malades de la covid réduit les décès (10% vs 44%. seulement 45 participants, Il faut un essai clinique. https://t.co/N0FAQYct2E
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
RT @RheumNow: Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, mo…
Anakinra studied in COVID(+) ARDS (nonICU) pts w/ high CRP L or ferritin; 29 high dose Anakinra vs 17 controls. At day 21, more survival with anakinra 90% vs. Controls 56% (p=0·009). Anakinra also more improved CRP+resp function (72 vs 50%) https://t.co/wx
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study https://t.co/ztaydX15mY
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study https://t.co/NS61b0CVQm
I am increasingly more avoidant of sharing observational studies on #COVID19, but this one is promising. @TheLancet IL-1 block with high-dose tocilizumab (anakinra) is safe and was ass with clinical improvement in 72% of patients. As always, RCTs needed
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
Small cohort study showing in non-ICU #COVID19 Pts with mod-severe ARDS, on non-mech vent, on HCQ & Kaletra, anakinra (IL-1 receptor antagonist) 5 mg/kg IV BID associated with ⬆️ survival at 21d, ⬇️ CRP & ⬆️ PaO2:FiO2 vs. standard care. RCTs are ne
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
Wow ! Paper published in medical journal Lancet showing Anakinra, a genetically engineered form of the protein interleukin 1 receptor antagonist, significantly increased survival in #covid19 patients with #ards #coronavirus #inflammation $mrna $tsoi h
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @Globalbiosec: Interleukin-1 blockade with high-dose #anakinra in patients with #COVID19, acute respiratory distress syndrome, and hyper…
RT @Globalbiosec: Interleukin-1 blockade with high-dose #anakinra in patients with #COVID19, acute respiratory distress syndrome, and hyper…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @fgiloarrojo: Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperin…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @ArditiMd: Lancet study. Anakinra as expected maybe useful. Need randomized study next. It is being done. This suggest the new COVID as…
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study https://t.co/06YIyEXB9p
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @BiotechMania: ARDSを合併するCOVID19に高用量アナキンラ(IL-1受容体拮抗、リウマチを適応に欧米で承認) が有望かも、との後ろ向き研究。 サイトカインストームをアクテムラ、ケブザラ(抗IL-6抗体)で抑えるのが必ずしもよい臨床結果ではなさそうな中…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @SRAnesthesiaICU: In this retrospective study of #COVID19 patients with ARDS managed with non-invasive ventilation outside ICU, high-dos…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study - The Lancet Rheumatology https://t.co/FE81427p1g
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
RT @srrezaie: Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospecti…
Small, but promising retrospective before-after trial of Anakinra (IL-1 Inhibitor) https://t.co/ANlutHQXKb Small retrospective before/after trial of high dose anakinra (5mg/kg IV BID), shows promising results in mortality & preventing progression of r
RT @SRAnesthesiaICU: In this retrospective study of #COVID19 patients with ARDS managed with non-invasive ventilation outside ICU, high-dos…
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
RT @ArditiMd: Lancet study. Anakinra as expected maybe useful. Need randomized study next. It is being done. This suggest the new COVID as…
RT @TYoungstein: We have certainly had some success with anakinra locally. Nice to see actual data even if retrospective. Well done.
Interleukin-1 blockade with high-dose #anakinra in patients with #COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study @JPUsdin https://t.co/tmHY2Ykjp6
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…
RT @TheLancetRheum: NEW Research—First study of #anakinra for hospitalised patients with severe #COVID19, acute respiratory distress syndro…